Roles of spleen and liver in development of the murine hematopoietic system

Frances M. Wolber, Ellen Leonard, Sara Michael, Christie M. Orschell-Traycoff, Mervin C. Yoder, Edward F. Srour

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Objective. Hematopoietic stem cells (HSCs) and colony-forming progenitor cells (CFCs) are believed to migrate from liver to bone marrow (BM) around the time of birth, where they remain throughout the animal's life. Although in mice the spleen is also a hematopoietic organ, neither the origin nor the contribution of spleen HSCs to hematopoietic homeostasis has been assessed relative to that of BM HSCs. To investigate these issues we quantitated CFC and HSC activity in the spleen, BM, peripheral blood, and liver of the mouse during ontogeny. Methods. CFCs were assessed by clonogenic colony formation, and HSCs by long-term reconstituting ability. Results. CFCs gradually increased in the BM and decreased in the liver with age. Increased prevalence of CFCs in fetal and pup blood occurred at day (d) 12 postcoitus (pc) and during the period of d16 pc to 4d postbirth, corresponding to the times when hematopoietic cells migrate from the yolk sac and/or aorta-gonad-mesonephros (AGM) to the fetal liver and from the neonatal liver to the BM, respectively. In the spleen, CFCs displayed two peaks of activity at 2d and 14d-15d postbirth. Spleen HSCs also fluctuated during this time period. Neonatal splenectomy did not alter CFC or HSC frequencies in the BM, but CFCs increased in the livers of splenectomized mice. Conclusion. These data demonstrate that the liver may act as a site of extramedullary hematopoiesis in the neonate, especially in the absence of the spleen, and imply that the spleen, BM, and liver cooperatively contribute to hematopoietic homeostasis.

Original languageEnglish (US)
Pages (from-to)1010-1019
Number of pages10
JournalExperimental Hematology
Volume30
Issue number9
DOIs
StatePublished - Sep 2002

Fingerprint

Hematopoietic System
Hematopoietic Stem Cells
Stem Cells
Spleen
Bone Marrow
Liver
Homeostasis
Mesonephros
Extramedullary Hematopoiesis
Yolk Sac
Gonads
Splenectomy
Fetal Blood
Aorta
Parturition

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Roles of spleen and liver in development of the murine hematopoietic system. / Wolber, Frances M.; Leonard, Ellen; Michael, Sara; Orschell-Traycoff, Christie M.; Yoder, Mervin C.; Srour, Edward F.

In: Experimental Hematology, Vol. 30, No. 9, 09.2002, p. 1010-1019.

Research output: Contribution to journalArticle

@article{cca45fd0a67843a08a06ae37fa398c98,
title = "Roles of spleen and liver in development of the murine hematopoietic system",
abstract = "Objective. Hematopoietic stem cells (HSCs) and colony-forming progenitor cells (CFCs) are believed to migrate from liver to bone marrow (BM) around the time of birth, where they remain throughout the animal's life. Although in mice the spleen is also a hematopoietic organ, neither the origin nor the contribution of spleen HSCs to hematopoietic homeostasis has been assessed relative to that of BM HSCs. To investigate these issues we quantitated CFC and HSC activity in the spleen, BM, peripheral blood, and liver of the mouse during ontogeny. Methods. CFCs were assessed by clonogenic colony formation, and HSCs by long-term reconstituting ability. Results. CFCs gradually increased in the BM and decreased in the liver with age. Increased prevalence of CFCs in fetal and pup blood occurred at day (d) 12 postcoitus (pc) and during the period of d16 pc to 4d postbirth, corresponding to the times when hematopoietic cells migrate from the yolk sac and/or aorta-gonad-mesonephros (AGM) to the fetal liver and from the neonatal liver to the BM, respectively. In the spleen, CFCs displayed two peaks of activity at 2d and 14d-15d postbirth. Spleen HSCs also fluctuated during this time period. Neonatal splenectomy did not alter CFC or HSC frequencies in the BM, but CFCs increased in the livers of splenectomized mice. Conclusion. These data demonstrate that the liver may act as a site of extramedullary hematopoiesis in the neonate, especially in the absence of the spleen, and imply that the spleen, BM, and liver cooperatively contribute to hematopoietic homeostasis.",
author = "Wolber, {Frances M.} and Ellen Leonard and Sara Michael and Orschell-Traycoff, {Christie M.} and Yoder, {Mervin C.} and Srour, {Edward F.}",
year = "2002",
month = "9",
doi = "10.1016/S0301-472X(02)00881-0",
language = "English (US)",
volume = "30",
pages = "1010--1019",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Roles of spleen and liver in development of the murine hematopoietic system

AU - Wolber, Frances M.

AU - Leonard, Ellen

AU - Michael, Sara

AU - Orschell-Traycoff, Christie M.

AU - Yoder, Mervin C.

AU - Srour, Edward F.

PY - 2002/9

Y1 - 2002/9

N2 - Objective. Hematopoietic stem cells (HSCs) and colony-forming progenitor cells (CFCs) are believed to migrate from liver to bone marrow (BM) around the time of birth, where they remain throughout the animal's life. Although in mice the spleen is also a hematopoietic organ, neither the origin nor the contribution of spleen HSCs to hematopoietic homeostasis has been assessed relative to that of BM HSCs. To investigate these issues we quantitated CFC and HSC activity in the spleen, BM, peripheral blood, and liver of the mouse during ontogeny. Methods. CFCs were assessed by clonogenic colony formation, and HSCs by long-term reconstituting ability. Results. CFCs gradually increased in the BM and decreased in the liver with age. Increased prevalence of CFCs in fetal and pup blood occurred at day (d) 12 postcoitus (pc) and during the period of d16 pc to 4d postbirth, corresponding to the times when hematopoietic cells migrate from the yolk sac and/or aorta-gonad-mesonephros (AGM) to the fetal liver and from the neonatal liver to the BM, respectively. In the spleen, CFCs displayed two peaks of activity at 2d and 14d-15d postbirth. Spleen HSCs also fluctuated during this time period. Neonatal splenectomy did not alter CFC or HSC frequencies in the BM, but CFCs increased in the livers of splenectomized mice. Conclusion. These data demonstrate that the liver may act as a site of extramedullary hematopoiesis in the neonate, especially in the absence of the spleen, and imply that the spleen, BM, and liver cooperatively contribute to hematopoietic homeostasis.

AB - Objective. Hematopoietic stem cells (HSCs) and colony-forming progenitor cells (CFCs) are believed to migrate from liver to bone marrow (BM) around the time of birth, where they remain throughout the animal's life. Although in mice the spleen is also a hematopoietic organ, neither the origin nor the contribution of spleen HSCs to hematopoietic homeostasis has been assessed relative to that of BM HSCs. To investigate these issues we quantitated CFC and HSC activity in the spleen, BM, peripheral blood, and liver of the mouse during ontogeny. Methods. CFCs were assessed by clonogenic colony formation, and HSCs by long-term reconstituting ability. Results. CFCs gradually increased in the BM and decreased in the liver with age. Increased prevalence of CFCs in fetal and pup blood occurred at day (d) 12 postcoitus (pc) and during the period of d16 pc to 4d postbirth, corresponding to the times when hematopoietic cells migrate from the yolk sac and/or aorta-gonad-mesonephros (AGM) to the fetal liver and from the neonatal liver to the BM, respectively. In the spleen, CFCs displayed two peaks of activity at 2d and 14d-15d postbirth. Spleen HSCs also fluctuated during this time period. Neonatal splenectomy did not alter CFC or HSC frequencies in the BM, but CFCs increased in the livers of splenectomized mice. Conclusion. These data demonstrate that the liver may act as a site of extramedullary hematopoiesis in the neonate, especially in the absence of the spleen, and imply that the spleen, BM, and liver cooperatively contribute to hematopoietic homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=0036754421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036754421&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(02)00881-0

DO - 10.1016/S0301-472X(02)00881-0

M3 - Article

C2 - 12225792

AN - SCOPUS:0036754421

VL - 30

SP - 1010

EP - 1019

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -